Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 8/20 | 0.36 |
| ▸ | SPR | P35270 | 8/20 | 0.34 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.34 |
| ▸ | PARK7 | Q99497 | 1/20 | 0.34 |
| ▸ | FASN | P49327 | 2/20 | 0.33 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17631978 | 0.83 | GRM5 (0.41) | GRM5 | |
| SCHEMBL17631972 | 0.83 | GRM5 (0.51) | GRM5PARK7 | |
| SCHEMBL17632318 | 0.82 | GRM5 (0.41) | GRM5UCHL1PARK7FASN | |
| SCHEMBL17632462 | 0.82 | FASN (0.35) | GRM5UCHL1PARK7FASN | |
| SCHEMBL17631750 | 0.81 | GRM5 (0.38) | GRM5UCHL1PARK7 | |
| SCHEMBL17631678 | 0.80 | GRM5 (0.41) | GRM5 | |
| SCHEMBL17631779 | 0.79 | GRM5 (0.44) | GRM5PARK7 | |
| SCHEMBL17632276 | 0.79 | F10 (0.41) | — | |
| SCHEMBL17631404 | 0.79 | TLR9 (0.39) | GRM5UCHL1PARK7 | |
| SCHEMBL17632587 | 0.76 | NPC1 (0.40) | GRM5FASN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197883-A1 | NOVEL COMPOUNDS | Mission Therapeutics Limited (GB) | 2017-08-02 | — | — | EP | claimed |
| WO-2016046530-A1 | NOVEL COMPOUNDS | MISSION THERAPEUTICS LTD (GB) | 2016-03-31 | — | — | WO | claimed |
| EP-3197883-A1 | NOVEL COMPOUNDS | Mission Therapeutics Limited (GB) | 2017-08-02 | — | — | EP | disclosed |
| WO-2016046530-A1 | NOVEL COMPOUNDS | MISSION THERAPEUTICS LTD (GB) | 2016-03-31 | — | — | WO | disclosed |